期刊文献+

沙格列汀联合二甲双胍治疗2型糖尿病有效性和安全性分析

下载PDF
导出
摘要 目的:评价沙格列汀联合二甲双胍治疗2型糖尿病(T2DM)的有效性和安全性。方法:以2015年1月至2016年6月我院内科收治的109例T2DM患者为研究对象,按随机性,并结合所对应的治疗方法将其分为对照组(盐酸吡格列酮联合二甲双胍)和观察组(沙格列汀联合二甲双胍),对照组54例,观察组55例,连续治疗16周后,对比两组患者的各项生化指标水平。结果:观察组的临床有效性和安全性均高于对照组(P<0.05)。结论:沙格列汀联合二甲双胍可显著降低T2DM的血糖水平,而且治疗后不良反应少,安全性高,值得采纳。
作者 计珂
机构地区 南京市雨花医院
出处 《中外女性健康研究》 2016年第15期81-82,共2页 Women's Health Research
  • 相关文献

参考文献5

二级参考文献25

  • 1Auqer DJ, Rob1 JA, Betebenner DA, et al. Discovery and preclini- cal profile of saxagliptin ( BMS - 477118 ) : a highly potent, long- acting, orally active dipeptidyl peptidase IV inhibitor for the treat- ment of type 2 diabetes[ J]. J Med Chem,2005,48 ( 15 ) :5025 - 5037.
  • 2ZHao G, Taunk PC, Magnin DR, et al. Diprolyl nitriles as potent dipeptidylpeptidase IV inhibitors [ J ]. Bioorg Med Chem Lett, 2005,15 ( 18 ) :3992 - 3995.
  • 3Celermajer DS, Sorensen KE, Gooch VM ,et al. Non-invasive detec- tion of endothelial dysfunction in children and adults at risk of ath- erosclerosis [ J ]. Lancet, 1992,340 (8828) : 1111 - 1115.
  • 4Caglayan E, Blaschke F, Takata Y,et al. Metabolic syndrome-inter- dependence of the cardiovascular and metabolic pathways [ J ]. Curr Opin Pharmacol,2005,5(2) :135 - 142.
  • 5Aronson D..Hyperglycemia and the pathobiology of diabetic compli- cations[ J]. Adv Cardio1,2008,45 : 1 - 16.
  • 6Coeeheri S. Approaches to prevention of cardiovascular complica- tions and events in diabetes mellitus [ J ]. Drugs, 2007,67 ( 7 ) : 997 - 1026.
  • 7Cobble ME, Frederich R. Saxagliptin for the treatment of type 2 di- abetes mellitus:assessing cardiovascular data [ J ]. Cardiovasc Dia- beto1,2012,11:6.
  • 8Erdoqdu O, Nathanson D, Sjoholm A,et al. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA-and Pl3K/Akt-dependent pathways and requires GLP-1 receptor [ J ]. Mol Cell Endocrinol, 2010,325 ( 1 - 2 ) : 26 - 35.
  • 9Matsubara J , Suqiyama S , Suqamura K , et al . A dipeptidylpeptidase -4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atheroselerotie lesion formation in apolipopro- tein E-deficient mice[ J]. J Am Coll Cardiol,2012,59(3) :265 - 276.
  • 10Vabl TP’Tauchi M,Durier TS,et al. Glucagon - like peptide-1( GLP - 1) receptors expressed on nerve terminals in the portal veinmediate the effects of endogenous GLP -1 on glucose tolerance in rats.Endocrinology 2007 ; 148(10) :4965 -4973.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部